Acutus Medical Income Statement 2024-2011 | AFIB

Brief overview of income trends at Acutus Medical

The conclusions below are based on five years of reported results. The revenue attributed to Acutus Medical moved from 2.8 million dollars to 20.2 million dollars between the two endpoints. The cumulative result was +610.8%, corresponding to roughly 48% per year. This pace points to rapid expansion of the business.

Gross profit was −$6.4 million at the start and $1 million at the end of the period (+115.8%). Revenue outpaced cost of revenue, allowing more sales to flow into gross profit. Gross margin moved from −225.9% to 5%. A wider margin shows that the economics of the core business improved.

EBITDA was −68.1 million dollars at the beginning and 240 thousand dollars at the end of the period (+100.4%). Changes in revenue did not translate into comparable EBITDA performance. EBITDA margin moved from −2401.8% to 1.2%. Higher profitability strengthens the quality of operating growth.

Net income moved from −$97 million at the start to −$9.5 million at the end. The loss narrowed, although sustainable profitability has not yet returned.

Conclusion

The results present an uneven picture without one dominant signal. Key strengths include a stronger final result, higher operating efficiency and revenue expansion. Caution is warranted because of limited operating profitability. Investors should continue to monitor margins, costs, and earnings quality.